Seeking Alpha


Send Message
View as an RSS Feed
View Leont68's Comments BY TICKER:
Latest  |  Highest rated
  • 3 Lessons From The Galena Scandal [View article]
    Glad Gale is back up, got scary for a while.
    Aug 27 12:55 PM | 1 Like Like |Link to Comment
  • Vringo -71.4% after resuming trading [View news story]
    patent "trolls" have been put on notice now. Glad i stopped trading patent stocks after i saw what happened to parkervision.
    Aug 15 12:59 PM | 4 Likes Like |Link to Comment
  • Appeals court rules against Vringo; shares halted [View news story]
    after the parker ruling I deciced not to trade patent related companies anymore...
    Aug 15 11:57 AM | 4 Likes Like |Link to Comment
  • POOF! There Goes The Short Thesis: Molycorp Receives $400MM Lifeline [View article]
    How many more quarters can MCP survive with this additional cash infusion?
    Aug 11 02:27 PM | 1 Like Like |Link to Comment
  • POOF! There Goes The Short Thesis: Molycorp Receives $400MM Lifeline [View article]
    SE keep writing articles... while i did not agree that MCP was a short it did make me stay away from it until it went under $2.

    Saved me a bunch of cash and time.
    Aug 7 09:37 PM | 1 Like Like |Link to Comment
  • Short Sellers And Seeking Alpha [View article]
    I agree with David. Most of the time the comments are even better than the articles themselves
    Aug 1 09:04 AM | 16 Likes Like |Link to Comment
  • ParkerVision Still Tremendously Overvalued [View article]
    I second Justin here, with this recent setback and all the negative publicity the shorts are having a field day now. But I think its going to go back up. I am selling 50 contracts of the $2 cash secured July put for a .49 premium , if I get assigned I will turn around and sell the $2 covered call.

    I am also buying 100 contracts of the January 2015 $5 call for $.10

    I am long this one , lets see what the future brings :)
    Jun 25 05:27 PM | 2 Likes Like |Link to Comment
  • ParkerVision: Investors Need To Watch Both The Courts And The USPTO Over Next 18 Months [View article]
    Thanks for the article
    Jun 25 12:55 PM | Likes Like |Link to Comment
  • Vringo's Q1 Report Shows Mixed Results: Is A Secondary Offering Just Around The Corner? [View article]
    Justin, as always, your articles are easy to read and very informative.

    I think VRNG at this price is a great opportunity.
    May 29 08:26 AM | 3 Likes Like |Link to Comment
  • Avanir Pharmaceuticals: Shares Could Have Significant Upside Ahead [View article]
    They just completed a new $50 million offering through Cowen. You think this will affect the share price on Monday? .

    No matter how you dice it I would see that as dilution. I am long btw
    May 9 06:43 PM | Likes Like |Link to Comment
  • Avanir prevails in patent case [View news story]
    today, they formally filed a 8k announcing the win.
    May 5 04:53 PM | 1 Like Like |Link to Comment
  • Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026 [View article]
    Nicely done avnr
    Apr 30 04:34 PM | Likes Like |Link to Comment
  • Expected Decision In Avanir Nuedexta Patent Litigation [View article]
    Once again, I have to thank Mr Ravisher for pointing out AVNR to me, made a bunch selling puts and calls these couple of months.
    Apr 30 03:28 PM | Likes Like |Link to Comment
  • MannKind resumes trading; shares +131.6% AH [View news story]
    I own 8 contracts of the june 2014 $5 call with a average price of $2.04, I plan on holding onto them till the beginning of june and then I will call those shares :)

    It was just a little gamble i took, the most I could lose is $1625.
    Apr 1 11:46 PM | Likes Like |Link to Comment
  • Exelixis trial for prostate-cancer drug given OK to continue [View news story]
    All I know is that gaps will be filled. Bought 1338 shares @$4.21 and have full confidence it will go back up. Company has enough cash on hand and news was not great today but surely exel did not deserve a selloff like this.
    Mar 26 09:47 PM | Likes Like |Link to Comment